Inside our body, there’s a small organ called the pancreas that plays a big role in our health. One of the most important things it does is make...
Vous n'êtes pas connecté
Researchers at Mount Sinai are developing a revolutionary pill using harmine, a DYRK1A inhibitor, to regenerate insulin-producing beta cells in the pancreas. Harmine alone tripled beta cell mass, and combined with a GLP-1 agonist like Ozempic, increased it by 700%. The team discovered that alpha cells could potentially be transformed into beta cells, offering a new source for insulin production.
Inside our body, there’s a small organ called the pancreas that plays a big role in our health. One of the most important things it does is make...
IMAGINE gaining weight every single time you eat anything – it’s most people’s worst nightmare. Unfortunately for Ashley O’Driscoll, who...
IMAGINE gaining weight every single time you eat anything – it’s most people’s worst nightmare. Unfortunately for Ashley O’Driscoll, who...
Lung tumors don't just evade the immune system. They reshape it at its source. Researchers from the Icahn School of Medicine at Mount Sinai and...
Experts see a place for pill formulations of GLP-1s as treatment for patients to switch to after reaching a target weight or blood sugar level on...
A Portuguese mouse has sparked debate by suggesting that immune cells native to the intestines travel to the pancreas to stimulate glucagon production...
WEDNESDAY, Sept. 3, 2025 -- Fourteen percent of individuals initiate glucagon-like peptide 1 receptor agonists (GLP-1 RAs) after bariatric surgery,...
WEDNESDAY, Sept. 3, 2025 -- Fourteen percent of individuals initiate glucagon-like peptide 1 receptor agonists (GLP-1 RAs) after bariatric surgery,...
Imagine a house that doesn't just shelter you but also stores electricity. It may sound like science fiction, but it's now closer to reality than ever...
Imagine a house that doesn't just shelter you but also stores electricity. It may sound like science fiction, but it's now closer to reality than ever...